Dan has more than two decades of leadership experience in corporate finance, technical accounting, financial reporting, financial management, capital market transactions, due diligence, and M&A support. Dan helps clients address the effects that business decisions have on their accounting and financial reporting functions, including all aspects of financial statement preparation, audit readiness, technical accounting implementation, US GAAP convergence, and risk advisory services.

Before joining CFGI, Dan served in several progressive leadership positions of increasing responsibility. Most recently, Dan was Senior Vice President, Controller and Chief Accounting Officer at Endo International, a $3 billion global life sciences company that develops and markets branded and generic pharmaceutical products. At Endo, Dan oversaw all aspects of the Company’s accounting function during a time of significant organizational change and rapid growth. Over 12 years, Dan was instrumental in driving the company’s strategy by leading the accounting and reporting activities associated with over $20 billion in company acquisitions, and several multi-billion capital market transactions, including a $3 billion transformational acquisition resulting in Endo’s re-domiciling to Ireland.

Dan also held leadership roles with Rohm and Haas Company, a former Fortune 300 chemical manufacturing company, including Financial Leader for the Americas and Technical Accounting Manager. He began his career at Ernst & Young, where he was an Assurance Manager focused on clients in the Pharmaceutical, Real Estate and Retail industries.

In addition to being licensed as a Certified Public Accountant (CPA), Dan is a member of the American Institute of Certified Public Accountants (AICPA) and the Pennsylvania Institute of Certified Public Accountants (PICPA). He received dual Bachelors of Science degrees in Accounting and Finance from Rutgers University.